PTGX | Protagonist Therapeutics Inc
Category: Consumer goods
Quick infos Headquarters: Newark, California, United States Trade prices Volume: 45.4M Market Cap: 382.44M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: May 10, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2023 - / -0.722- / 2.5MMarch 15, 2023 -0.69 / -0.6682- / 3.33MNovember 9, 2022 - / -0.9146- / 225KAugust 4, 2022 -0.84 / -0.9353859K / 460KBeat! May 4, 2022 -0.43 / -0.539925.7M / 21.18MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 10, 2022 11.45 11.34 11.70
11.26
858.86K 3.81% Aug 9, 2022 11.03 11.66 11.97
10.67
932.86K -5.4% Aug 8, 2022 11.66 11.44 11.70
11.19
1.03M 1.75% Aug 5, 2022 11.46 11.45 11.83
11.02
831.00K -2.13% Aug 4, 2022 11.71 11.32 11.73
11.11
1.42M 4.46% Aug 3, 2022 11.21 10.76 11.35
10.63
1.54M 5.46% Aug 2, 2022 10.63 9.70 10.68
9.70
924.94K 7.92% Aug 1, 2022 9.85 9.90 10.34
9.77
1.03M -1.01% Jul 29, 2022 9.95 10.18 10.18
9.63
509.96K -2.93% Jul 28, 2022 10.25 10.18 10.34
9.78
526.85K 1.18% view more
PTGX
More profiles and info about the company News
Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Business Is Yet to Catch Up With Its Share Price finance.yahoo.com Apr 17, 2023 6:35 am Protagonist Therapeutics prices $100M offering seekingalpha.com Apr 5, 2023 3:14 pm
Protagonist Therapeutics Announces Highly Statistically Significant Results from the Randomized Withdrawal Portion of the REVIVE Study of Rusfertide in Polycythemia Vera finance.yahoo.com Apr 5, 2023 7:30 am Protagonist falls on $100M public offering seekingalpha.com Apr 5, 2023 4:43 am
Protagonist Therapeutics Announces Proposed Underwritten Public Offering of Common Stock finance.yahoo.com Apr 4, 2023 4:11 pm
Analysts Just Made A Major Revision To Their Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Revenue Forecasts finance.yahoo.com Mar 20, 2023 6:08 am Protagonist GAAP EPS of -$0.69 misses by $0.10 seekingalpha.com Mar 16, 2023 4:46 am Sangamo, Protagonist, and Eiger among biotechs with exposure to Silicon Valley Bank seekingalpha.com Mar 11, 2023 10:26 am
Protagonist Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update finance.yahoo.com Mar 15, 2023 4:01 pm
Protagonist (PTGX) Up on Positive Results From FRONTIER Study finance.yahoo.com Mar 8, 2023 12:19 pm Johnson & Johnson, Protagonist succeed in mid-stage trial for psoriasis candidate seekingalpha.com Mar 7, 2023 10:00 pm CDTX, PTGX and TAST among premarket gainers seekingalpha.com Mar 7, 2023 9:38 pm
Why Protagonist Therapeutics Shares Are Trading Higher Today finance.yahoo.com Mar 7, 2023 11:54 am
Protagonist Therapeutics (PTGX) Moves 10.7% Higher: Will This Strength Last? finance.yahoo.com Jan 25, 2023 3:24 am
Protagonist Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com Dec 21, 2022 4:05 pm
Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit finance.yahoo.com Dec 1, 2022 7:05 am
Protagonist Reports Second Quarter 2022 Financial Results and Provides Corporate Update finance.yahoo.com Nov 29, 2022 4:05 pm
Protagonist Therapeutics Third Quarter 2022 Earnings: US$0.64 loss per share (vs US$0.70 loss in 3Q 2021) finance.yahoo.com Nov 29, 2022 5:11 am
Protagonist Therapeutics Reports Granting of Inducement Award finance.yahoo.com Nov 16, 2022 4:05 pm
How Much Upside is Left in Protagonist Therapeutics (PTGX)? Wall Street Analysts Think 337% finance.yahoo.com Nov 11, 2022 9:55 am This company doesn't provide a dividend.
Talk about Protagonist Therapeutics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
investors.protagonist-inc.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet